US646572A
(en)
*
|
1899-03-15 |
1900-04-03 |
Archibald C Floyd |
Bath-cabinet.
|
CH624395A5
(no)
*
|
1976-01-08 |
1981-07-31 |
Ciba Geigy Ag |
|
US4343940A
(en)
|
1979-02-13 |
1982-08-10 |
Mead Johnson & Company |
Anti-tumor quinazoline compounds
|
EP0054132B1
(de)
*
|
1980-12-12 |
1984-10-10 |
Dr. Karl Thomae GmbH |
Neue Pyrimidinone, ihre Herstellung und Arzneimittel mit einem Gehalt an diesen Stoffen
|
US4422711A
(en)
|
1981-12-21 |
1983-12-27 |
Amp Incorporated |
Active pin contact
|
US4431440A
(en)
*
|
1981-02-20 |
1984-02-14 |
American Cyanamid Company |
Method to alter or control the development and/or the life cycle of various plant species
|
US4588812A
(en)
*
|
1984-05-30 |
1986-05-13 |
Pennwalt Corporation |
Substituted 2,3-dihydro-5H-thiazolo[2,3,-b]quinazoline derivatives
|
GB8429739D0
(en)
*
|
1984-11-24 |
1985-01-03 |
Fbc Ltd |
Fungicides
|
GB8513754D0
(en)
|
1985-05-31 |
1985-07-03 |
Jones T R |
Anti-cancer quinazoline derivatives
|
GB8811435D0
(en)
*
|
1988-05-13 |
1988-06-15 |
Ici Plc |
Fungicides
|
DE68905765T3
(de)
|
1988-11-21 |
1998-03-26 |
Zeneca Ltd |
Fungizide.
|
GB8827988D0
(en)
|
1988-11-30 |
1989-01-05 |
Smith Kline French Lab |
Chemical compounds
|
IE62559B1
(en)
*
|
1989-02-02 |
1995-02-08 |
Ici Plc |
Fungicides
|
US5145856A
(en)
|
1989-02-10 |
1992-09-08 |
Imperial Chemical Industries Plc |
Fungicides
|
BE1003002A6
(fr)
|
1989-03-21 |
1991-10-22 |
Coppe Jan |
Composition a mettre en oeuvre pour le traitement de la calvitie, et procedes faisant usage de celle-ci.
|
GB8914797D0
(en)
*
|
1989-06-28 |
1989-08-16 |
Ici Plc |
Fungicides
|
US5240928A
(en)
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
US5187779A
(en)
*
|
1989-08-11 |
1993-02-16 |
Micral, Inc. |
Memory controller with synchronous processor bus and asynchronous i/o bus interfaces
|
GB9016783D0
(en)
|
1989-09-01 |
1990-09-12 |
Ici Plc |
Agrochemical compositions
|
GB8928547D0
(en)
*
|
1989-12-18 |
1990-02-21 |
Ici Plc |
Fungicides
|
AU6812790A
(en)
|
1989-12-22 |
1991-06-27 |
Ici Americas Inc. |
Fungicidal compounds
|
GB9000130D0
(en)
*
|
1990-01-04 |
1990-03-07 |
Ici Plc |
Fungicides
|
US5264439A
(en)
|
1990-02-13 |
1993-11-23 |
Merck & Co., Inc. |
Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element
|
CA2037630C
(en)
*
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
GB9012017D0
(en)
*
|
1990-05-30 |
1990-07-18 |
Ici Plc |
Fungicidal compounds
|
GB9013615D0
(en)
|
1990-06-19 |
1990-08-08 |
Wellcome Found |
Pharmaceutical compounds
|
US5225318A
(en)
*
|
1990-07-02 |
1993-07-06 |
Ocg Microelectronic Materials, Inc. |
Selected photoactive methylolated cyclohexanol compounds and their use in forming positive resist image patterns
|
GB9016584D0
(en)
*
|
1990-07-27 |
1990-09-12 |
Ici Plc |
Fungicides
|
GB9016578D0
(en)
|
1990-07-27 |
1990-09-12 |
Ici Plc |
Fungicides
|
MY107955A
(en)
*
|
1990-07-27 |
1996-07-15 |
Ici Plc |
Fungicides.
|
GB9018408D0
(en)
|
1990-08-22 |
1990-10-03 |
Ici Plc |
Fungicides
|
US5110471A
(en)
*
|
1990-08-30 |
1992-05-05 |
Conoco Specialty Products Inc. |
High efficiency liquid/liquid hydrocyclone
|
GB9023294D0
(en)
|
1990-10-25 |
1990-12-05 |
Ici Plc |
Fungicides
|
US5290780A
(en)
*
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5385894A
(en)
*
|
1991-03-06 |
1995-01-31 |
Merck & Co., Inc. |
Disubstituted 6-aminoquinazolinones
|
NZ242290A
(en)
|
1991-04-15 |
1994-12-22 |
Zeneca Ltd |
Pyridyl and pyrimidinyl substituted oxime-o-benzyl ether derivatives; preparatory processes, fungicidal compositions and an intermediate
|
US5252574A
(en)
|
1991-04-26 |
1993-10-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted thiophene or furan
|
US5162325A
(en)
|
1991-05-07 |
1992-11-10 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted benzyl element
|
CA2102780C
(en)
*
|
1991-05-10 |
2007-01-09 |
Alfred P. Spada |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
US5158953A
(en)
|
1991-08-13 |
1992-10-27 |
National Science Council |
2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
|
US6011068A
(en)
*
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US6313146B1
(en)
|
1991-08-23 |
2001-11-06 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US6031003A
(en)
*
|
1991-08-23 |
2000-02-29 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
DE4130298A1
(de)
|
1991-09-12 |
1993-03-18 |
Basf Ag |
Fungizide mischungen
|
GB9126260D0
(en)
*
|
1991-12-11 |
1992-02-12 |
Pfizer Ltd |
Therapeutic agents
|
DE4243340A1
(de)
*
|
1992-12-21 |
1994-06-23 |
Sued Chemie Ag |
Sorptionsmittel
|
US5420133A
(en)
*
|
1993-03-19 |
1995-05-30 |
Merck & Co., Inc. |
Quinazolinones substituted with phenoxyphenylacetic acid derivatives
|
US5401745A
(en)
*
|
1993-03-19 |
1995-03-28 |
Merck & Co., Inc. |
Quinazolinones substituted with phenoxyphenylacetic acid derivatives
|
ATE136734T1
(de)
|
1993-09-24 |
1996-05-15 |
Basf Ag |
Fungizide mischungen
|
US5721236A
(en)
*
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
JP3364727B2
(ja)
*
|
1993-10-22 |
2003-01-08 |
イハラケミカル工業株式会社 |
2,2−ビス(3,5−ジ置換−4−ヒドロキシフェニル)プロパン誘導体とその製造方法およびこの誘導体を用いるピロガロールの製造法
|
US5464854A
(en)
*
|
1993-11-11 |
1995-11-07 |
Depadova; Anathony S. |
Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S.
|
US5756502A
(en)
*
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
EP1203761B1
(en)
*
|
1994-10-21 |
2005-01-19 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active compounds
|
GB2295387A
(en)
|
1994-11-23 |
1996-05-29 |
Glaxo Inc |
Quinazoline antagonists of alpha 1c adrenergic receptors
|
GB9423911D0
(en)
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
DE19501481A1
(de)
*
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,8-Disubstituierte Chinazolinone
|
DE122005000053I2
(de)
|
1995-03-30 |
2008-01-17 |
Pfizer Prod Inc |
Chinazolinderivate
|
MY115814A
(en)
|
1995-06-16 |
2003-09-30 |
Bayer Ip Gmbh |
Crop protection compositions
|
WO1997006678A1
(de)
|
1995-08-17 |
1997-02-27 |
Basf Aktiengesellschaft |
Fungizide mischungen eines oximethercarbonsäureamids mit azolderivaten
|
US6897213B1
(en)
|
1995-11-21 |
2005-05-24 |
Warner-Lambert Company |
Heterocycles as cholecystokinin (CCK) ligands
|
JPH09241110A
(ja)
*
|
1996-03-08 |
1997-09-16 |
Sumitomo Chem Co Ltd |
殺菌剤組成物
|
JP2000509054A
(ja)
*
|
1996-04-26 |
2000-07-18 |
ビーエーエスエフ アクチェンゲゼルシャフト |
殺菌剤混合物
|
BR9708873B1
(pt)
*
|
1996-04-26 |
2009-05-05 |
|
mistura fungicida, e, processo para controlar fungos nocivos.
|
EP0901487B9
(en)
|
1996-05-15 |
2004-09-29 |
Pfizer Inc. |
2,3,6 trisubstituted-4(3h)-quinazolinones
|
ID19609A
(id)
*
|
1996-07-13 |
1998-07-23 |
Glaxo Group Ltd |
Senyawa-senyawa heterosiklik
|
DE19629825A1
(de)
|
1996-07-24 |
1998-01-29 |
Bayer Ag |
Dihydrofuran-carboxamide
|
CA2265495A1
(en)
|
1996-09-13 |
1998-03-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-hormonal method of contraception
|
US6225318B1
(en)
*
|
1996-10-17 |
2001-05-01 |
Pfizer Inc |
4-aminoquinazolone derivatives
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
EA001963B1
(ru)
|
1997-02-28 |
2001-10-22 |
Пфайзер Продактс Инк. |
Атропизомеры 3-арил-4(3н)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов
|
ID23435A
(id)
*
|
1997-02-28 |
2000-04-20 |
Pfizer Prod Inc |
Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns
|
US5948775A
(en)
*
|
1997-03-19 |
1999-09-07 |
American Home Products Corporation |
2- or 3-(substitutedaminoalkoxyphenyl)quinazolin-4-ones
|
FR2762841B1
(fr)
*
|
1997-04-30 |
1999-07-02 |
Jouveinal Inst Rech |
Diazepino-indolones inhibitrices de phosphodiesterases iv
|
CO5050364A1
(es)
|
1997-05-28 |
2001-06-27 |
Basf Ag |
Metodo para controlar hongos nocivos
|
AU749368B2
(en)
*
|
1997-06-04 |
2002-06-27 |
Basf Aktiengesellschaft |
Fungicidal mixture
|
US6060479A
(en)
*
|
1997-06-09 |
2000-05-09 |
Pfizer Inc |
Quinazoline-4-one AMPA antagonists
|
US6627755B1
(en)
|
1997-06-09 |
2003-09-30 |
Pfizer Inc |
Quinazolin-4-one AMPA antagonists
|
US5753851A
(en)
*
|
1997-06-16 |
1998-05-19 |
The United States Of America As Represented By The Secretary Of The Army |
Spinning mine with concentrated projectiles
|
EP0900567A3
(en)
|
1997-09-05 |
2001-05-02 |
Pfizer Products Inc. |
Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
US20030069231A1
(en)
|
1999-10-12 |
2003-04-10 |
Klaus Rudolf |
Modified aminoacids, pharmaceuticals containing these compounds and method for their production
|
JP2959765B2
(ja)
*
|
1997-12-12 |
1999-10-06 |
日本たばこ産業株式会社 |
3−ピペリジル−4−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
|
TW431861B
(en)
*
|
1997-12-18 |
2001-05-01 |
Basf Ag |
Fungicidal mixtures based on amide compounds and azoles
|
GB9800569D0
(en)
*
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
PL342243A1
(en)
*
|
1998-01-27 |
2001-06-04 |
Aventis Pharm Prod Inc |
Substituted oxoazaheterocyclic inhibitors of the factor xa
|
JPH11279158A
(ja)
|
1998-02-09 |
1999-10-12 |
Pfizer Prod Inc |
キナゾリン―4―オン誘導体の製造方法
|
JPH11228643A
(ja)
*
|
1998-02-17 |
1999-08-24 |
Menicon Co Ltd |
眼用レンズ材料およびその製法
|
WO1999044612A1
(en)
|
1998-03-02 |
1999-09-10 |
Cocensys, Inc. |
Substituted quinazolines and analogs and the use thereof
|
US6337332B1
(en)
*
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
US6187779B1
(en)
*
|
1998-11-20 |
2001-02-13 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
|
US6225315B1
(en)
*
|
1998-11-30 |
2001-05-01 |
Pfizer Inc |
Method of treating nitrate-induced tolerance
|
GB9828340D0
(en)
|
1998-12-22 |
1999-02-17 |
Novartis Ag |
Organic compounds
|
US6270781B1
(en)
*
|
1999-01-08 |
2001-08-07 |
Maxim Pharmaceuticals, Inc. |
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
FR2792938B1
(fr)
|
1999-04-28 |
2001-07-06 |
Warner Lambert Co |
NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
|
JP4831906B2
(ja)
*
|
1999-08-27 |
2011-12-07 |
ケモセントリックス, インコーポレイテッド |
Cxcr3機能を調節するための複素環式化合物および方法
|
US6890930B1
(en)
*
|
1999-09-28 |
2005-05-10 |
3-Dimensional Pharmaceuticals, Inc. |
Quinazolinones
|
US7060706B1
(en)
*
|
1999-09-28 |
2006-06-13 |
3-Dimensional Pharmaceuticals, Inc. |
Quinazolinones
|
US6545004B1
(en)
*
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
US6562830B1
(en)
*
|
1999-11-09 |
2003-05-13 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives
|
US6664390B2
(en)
|
2000-02-02 |
2003-12-16 |
Warner-Lambert Company Llc |
Method for the simplified production of (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazoline-4-yl]-amine
|
US6697213B2
(en)
*
|
2000-03-31 |
2004-02-24 |
Seagate Technology Llc |
Cover including multiple cover plates with damped layers
|
MXPA02010322A
(es)
|
2000-04-19 |
2004-09-10 |
Univ Johns Hopkins |
Metodos para la prevencion y tratamiento de trastornos gastrointestinales.
|
ES2527754T3
(es)
*
|
2000-04-25 |
2015-01-29 |
Icos Corporation |
Inhibidores de la isoforma delta de la fosfatidilinositol 3-quinasa humana
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
DE60136187D1
(de)
*
|
2000-08-11 |
2008-11-27 |
Japan Tobacco Inc |
Calciumrezeptor-antagonisten
|
EP1188438A1
(en)
|
2000-09-15 |
2002-03-20 |
Warner-Lambert Company |
Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
|
JP2004509876A
(ja)
*
|
2000-09-20 |
2004-04-02 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
4−アミノ−キナゾリン
|
EP1326863A2
(en)
*
|
2000-09-22 |
2003-07-16 |
Ortho-McNeil Pharmaceutical, Inc. |
Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
|
EP1331950B1
(en)
*
|
2000-10-13 |
2009-10-14 |
The Johns Hopkins University |
Ex vivo methods and compositions for nucleic acid delivery
|
EP1404654A4
(en)
*
|
2000-10-25 |
2008-12-03 |
Smithkline Beecham Corp |
CALCILYTIC COMPOUNDS
|
JP4259877B2
(ja)
|
2000-12-11 |
2009-04-30 |
アムジエン・インコーポレーテツド |
Cxcr3アンタゴニスト
|
US6900220B2
(en)
*
|
2001-01-02 |
2005-05-31 |
Syntex (U.S.A.) Llc |
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
|
HUP0303249A3
(en)
|
2001-02-22 |
2007-03-28 |
Sankyo Co |
Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
|
JPWO2002094790A1
(ja)
|
2001-05-23 |
2004-09-09 |
三菱ウェルファーマ株式会社 |
縮合ヘテロ環化合物およびその医薬用途
|
EP1392684B1
(en)
*
|
2001-06-01 |
2006-09-13 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinases
|
US7220777B2
(en)
*
|
2001-10-15 |
2007-05-22 |
Smithkline Beecham P.L.C. |
Lactam derivatives as antagonists for human 11cby receptors
|
JP2005511581A
(ja)
|
2001-11-07 |
2005-04-28 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
US20040110777A1
(en)
*
|
2001-12-03 |
2004-06-10 |
Annis Gary David |
Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
|
EP1471910A2
(en)
*
|
2002-01-17 |
2004-11-03 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
|
US6559293B1
(en)
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
WO2003070701A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Cytokinetics, Inc. |
Syntheses of quinazolinones
|
AU2003229724B2
(en)
|
2002-04-26 |
2009-07-02 |
Altana Pharma Ag |
Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
|
RU2004135386A
(ru)
|
2002-05-06 |
2005-07-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Тиадиазолы или оксадиазолы и их применение в качестве ингибиторов протеинкиназы jak
|
US7214800B2
(en)
*
|
2002-05-09 |
2007-05-08 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
JP2006506401A
(ja)
*
|
2002-05-23 |
2006-02-23 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害薬
|
JP2005536475A
(ja)
*
|
2002-05-23 |
2005-12-02 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物、および方法
|
PT1551834E
(pt)
*
|
2002-05-23 |
2010-09-30 |
Novartis Vaccines & Diagnostic |
Compostos de quinazolinona substituídos
|
WO2004009036A2
(en)
*
|
2002-07-23 |
2004-01-29 |
Cytokinetics, Inc. |
Compounds compositions and methods
|
US20040048853A1
(en)
|
2002-08-21 |
2004-03-11 |
Gustave Bergnes |
Compounds, compositions, and methods
|
US20040242572A1
(en)
|
2002-08-24 |
2004-12-02 |
Boehringer Ingelheim International Gmbh |
New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
|
EP1558083A4
(en)
|
2002-09-30 |
2008-04-16 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
KR20110050745A
(ko)
|
2002-10-03 |
2011-05-16 |
탈자진 인코포레이티드 |
혈관항상성 유지제 및 그의 사용 방법
|
GB0223730D0
(en)
*
|
2002-10-11 |
2002-11-20 |
Novartis Ag |
Organic compounds
|
EP1553947A4
(en)
*
|
2002-10-21 |
2006-11-29 |
Bristol Myers Squibb Co |
QUINAZOLINONES AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
|
AU2003291761A1
(en)
*
|
2002-11-04 |
2004-06-07 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
FR2846657B1
(fr)
*
|
2002-11-05 |
2004-12-24 |
Servier Lab |
Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US20040142958A1
(en)
*
|
2002-12-13 |
2004-07-22 |
Neurogen Corporation |
Combination therapy for the treatment of pain
|
GB0230015D0
(en)
*
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
AU2004212421B2
(en)
|
2003-02-07 |
2009-08-20 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl substituted pyrolls useful as inhibitors of protein kinases
|
TW200508224A
(en)
|
2003-02-12 |
2005-03-01 |
Bristol Myers Squibb Co |
Cyclic derivatives as modulators of chemokine receptor activity
|
CL2004000409A1
(es)
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
ATE398125T1
(de)
|
2003-03-12 |
2008-07-15 |
Millennium Pharm Inc |
Chinazolin-derivate als tgf-beta-inhibitoren
|
US7488757B2
(en)
*
|
2003-03-24 |
2009-02-10 |
Becton, Dickinson And Company |
Invisible antimicrobial glove and hand antiseptic
|
KR20050122220A
(ko)
|
2003-03-25 |
2005-12-28 |
다케다 샌디에고, 인코포레이티드 |
디펩티딜 펩티다제 억제제
|
EP1614676A4
(en)
|
2003-03-27 |
2009-03-25 |
Kirin Pharma Kk |
PHOSPHORUS TRANSPORT IN VIVO INHIBITOR COMPOUND AND MEDICAMENT CONTAINING THE SAME
|
EP2258365B1
(en)
*
|
2003-03-28 |
2013-05-29 |
Novartis Vaccines and Diagnostics, Inc. |
Use of organic compounds for immunopotentiation
|
WO2004092120A2
(en)
*
|
2003-04-07 |
2004-10-28 |
Nps Pharmaceuticals, Inc. |
Pyrimidinone compounds as calcilytics
|
US20070161792A1
(en)
*
|
2003-04-07 |
2007-07-12 |
Nps Pharmacueticals, Inc |
Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones
|
CN1835928A
(zh)
*
|
2003-04-07 |
2006-09-20 |
Nps制药公司 |
作为钙敏感受体拮抗剂的嘧啶酮化合物
|
GB0309009D0
(en)
*
|
2003-04-22 |
2003-05-28 |
Astrazeneca Ab |
Quinazoline derivatives
|
GEP20084342B
(en)
*
|
2003-05-22 |
2008-03-25 |
|
Composition comprising a pde4 inhibitor and a pde5 inhibitor
|
US7625909B2
(en)
*
|
2003-05-23 |
2009-12-01 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted quinazolinone compounds
|
JP2007501854A
(ja)
|
2003-05-27 |
2007-02-01 |
ファイザー・プロダクツ・インク |
受容体型チロシンキナーゼ阻害薬としてのキナゾリン類およびピリド[3,4−d]ピリミジン類
|
CA2525383C
(en)
|
2003-06-06 |
2012-03-06 |
Arexis Ab |
Use of heterocyclic compounds as scce inhibitors
|
US20050038051A1
(en)
*
|
2003-06-09 |
2005-02-17 |
Jodi Nunnari |
Novel molecules for regulating cell death
|
JP2006527737A
(ja)
|
2003-06-16 |
2006-12-07 |
アルタナ ファルマ アクチエンゲゼルシャフト |
肺サーファクタントとpde5阻害剤とを含有する肺疾病の治療用の組成物
|
WO2005002585A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
AU2004255581A1
(en)
*
|
2003-07-02 |
2005-01-20 |
F. Hoffmann-La Roche Ag |
Arylamine-substituted quinazolinone compounds
|
CA2531327A1
(en)
*
|
2003-07-03 |
2005-01-13 |
Myriad Genetics, Inc. |
Compounds and therapeutical use thereof
|
US20050043239A1
(en)
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
WO2005019190A2
(en)
*
|
2003-08-20 |
2005-03-03 |
Vertex Pharmaceuticals Incorporated |
(4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors
|
WO2005020897A2
(en)
*
|
2003-08-22 |
2005-03-10 |
Dendreon Corporation |
Compositions and methods for the treatment of disease associated with trp-p8 expression
|
US20050059862A1
(en)
*
|
2003-09-12 |
2005-03-17 |
Scimed Life Systems, Inc. |
Cannula with integrated imaging and optical capability
|
CN1882573A
(zh)
*
|
2003-09-16 |
2006-12-20 |
阿斯利康(瑞典)有限公司 |
作为酪氨酸激酶抑制剂的喹唑啉衍生物
|
US20050059851A1
(en)
*
|
2003-09-17 |
2005-03-17 |
Vincent Ardizzone |
Flexible magnetic pad with multi-directional constantly alternating polarity zones
|
TW200524892A
(en)
|
2003-09-24 |
2005-08-01 |
Glaxo Group Ltd |
Calcilytic compounds
|
GB0325175D0
(en)
*
|
2003-10-28 |
2003-12-03 |
Novartis Ag |
Organic compounds
|
GB0326459D0
(en)
|
2003-11-13 |
2003-12-17 |
Astrazeneca Ab |
Quinazoline derivatives
|
MXPA06005736A
(es)
|
2003-11-19 |
2006-12-14 |
Chiron Corp |
Compuestos de quinazolinona con bioacumulacion reducida.
|
NZ590160A
(en)
*
|
2003-11-21 |
2012-07-27 |
Array Biopharma Inc |
AKT protein kinase inhibitors
|
ES2371469T3
(es)
|
2003-12-01 |
2012-01-03 |
Kudos Pharmaceuticals Limited |
Inhibidores de reparación de daños en adn para el tratamiento del cáncer.
|
US20050136085A1
(en)
*
|
2003-12-19 |
2005-06-23 |
David Bellamy |
Panthenol and natural organic extracts for reducing skin irritation
|
CN1898249A
(zh)
*
|
2003-12-19 |
2007-01-17 |
默克公司 |
有丝分裂驱动蛋白抑制剂
|
CA2549641A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
CA2552664A1
(en)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methods for treating and preventing hypertension and hypertension-related disorders
|
US20050227309A1
(en)
|
2004-01-21 |
2005-10-13 |
Corry Schuyler B |
Optically-detectable enzyme substrates and their method of use
|
RU2358969C2
(ru)
|
2004-02-13 |
2009-06-20 |
Баниу Фармасьютикал Ко., Лтд. |
Конденсированное 4-оксопиримидиновое производное
|
JP4838792B2
(ja)
|
2004-03-05 |
2011-12-14 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Pde5阻害剤のための新規の使用
|
JP2007530595A
(ja)
|
2004-03-26 |
2007-11-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Erk2のピリジンインヒビターおよびそれらの使用
|
NZ551340A
(en)
|
2004-04-22 |
2010-10-29 |
Boehringer Ingelheim Int |
Pharmaceutical composition comprising flibanserin and a melanocortin agonist for the treatment of premenstrual disorder or sexual aversion disorder
|
EP1742924A4
(en)
*
|
2004-05-06 |
2010-10-06 |
Glaxosmithkline Llc |
CALCILYTIC COMPOUNDS
|
CA2730540A1
(en)
*
|
2004-05-13 |
2005-12-01 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
JP2008500338A
(ja)
*
|
2004-05-25 |
2008-01-10 |
イコス・コーポレイション |
造血細胞の異常増殖を治療及び/又は予防する方法
|
KR20070038500A
(ko)
|
2004-06-04 |
2007-04-10 |
아스트라제네카 아베 |
erbB 수용체 타이로신 키나제로서의 퀴나졸린 유도체
|
US7429604B2
(en)
*
|
2004-06-15 |
2008-09-30 |
Bristol Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
US7939538B2
(en)
*
|
2004-06-28 |
2011-05-10 |
Amgen Inc. |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
|
TW200605430A
(en)
*
|
2004-07-20 |
2006-02-01 |
Avision Inc |
Electrical magnetic interference inspecting system
|
US7203079B2
(en)
*
|
2004-07-23 |
2007-04-10 |
System General Corp. |
Switching controller having frequency hopping for power supplies
|
US20060025420A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Boehringer Ingelheimn International GmbH |
Pharmaceutical compositions for the treatment of female sexual disorders
|
US7718658B2
(en)
*
|
2004-09-02 |
2010-05-18 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
US20060063707A1
(en)
*
|
2004-09-17 |
2006-03-23 |
Lifelike Biomatic, Inc. |
Compositions for enhancing memory and methods therefor
|
US8011027B2
(en)
*
|
2004-11-17 |
2011-09-06 |
Interspiro, Inc. |
Protective seal mechanism
|
JP2006151028A
(ja)
*
|
2004-11-25 |
2006-06-15 |
Sumitomo Rubber Ind Ltd |
タイヤとリムとの組立体およびこれに用いるサポートリング
|
US7466645B2
(en)
*
|
2004-12-21 |
2008-12-16 |
Panasonic Corporation |
OFDM signal receiving apparatus
|
US20070032506A1
(en)
*
|
2005-07-02 |
2007-02-08 |
Peter Giannousis |
Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride
|
RU2008130111A
(ru)
*
|
2005-12-22 |
2010-01-27 |
Алькон Рисерч, Лтд. (Us) |
(индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний
|
TWI338846B
(en)
*
|
2006-12-22 |
2011-03-11 |
Univ Nat Pingtung Sci & Tech |
A method for grid-based data clustering
|
EP1964548A1
(en)
|
2007-03-02 |
2008-09-03 |
Novartis AG |
Pharmaceutical compositions comprising a calcilytic agent
|
CA2747417C
(en)
*
|
2009-01-08 |
2017-01-03 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|